Name | MT-802 |
---|
Description | MT-802 is a potent BTK degrader based on PROTAC technology, with a DC50 of 1 nM. MT-802 has potential to treat C481S mutant chronic lymphocytic leukemia (CLL)[1]. |
---|---|
Related Catalog | |
Target |
DC50: 1 nM (BTK)[1]. |
In Vitro | MT-802 degrades BTK with a DC50 of 9.1 nM with maximal degradation being observed by 250 nM[1]. |
References |
Molecular Formula | C41H41N9O8 |
---|---|
Molecular Weight | 787.82 |
Storage condition | -20°C |